Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
493.05M
Enterprise Value
412.90M
Income
-109.39M
Sales
48.55M
Book/sh
1.71
Cash/sh
2.70
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
130
IPO
Dec 22, 2015
P/E
-
Forward P/E
-
PEG
-
P/S
10.16
P/B
5.46
P/C
3.45
P/FCF
-
EV/EBITDA
-
EV/Sales
8.50
Quick Ratio
6.40
Current Ratio
6.74
Debt/Eq
0.70
LT Debt/Eq
0.68
Option/Short
Yes / Yes
EPS (ttm)
-2.28
EPS next Y
-1.93
EPS next Q
-0.52
EPS this Y
-37.51%
EPS next Y
15.63%
EPS next 5Y
2.71%
EPS past 3/5Y
8.64% 35.96%
Sales past 3/5Y
29.09% 48.10%
EPS Y/Y TTM
-11.42%
Sales Y/Y TTM
90.63%
EPS Q/Q
-77.96%
Sales Q/Q
117.82%
Insider Own
11.93%
Insider Trans
0.58%
Inst Own
39.64%
Inst Trans
29.19%
ROA
-66.88%
ROE
-118.24%
ROIC
-71.89%
Gross Margin
54.87%
Oper. Margin
-223.22%
Profit Margin
-225.34%
SMA20
7.79%
SMA50
1.54%
SMA200
29.47%
Trades
Shs Outstand
52.86M
Shs Float
46.57M
52W High
10.64 -12.36%
52W Low
4.79 94.68%
Volatility
8.90% 6.37%
ATR (14)
0.56
RSI (14)
55.88
Beta
1.04
Rel Volume
1.30
Avg Volume
704.74K
Volume
63,563
Perf Week
24.17%
Perf Month
-6.38%
Perf Quarter
78.47%
Perf Half Y
82.84%
Perf YTD
68.93%
Perf Year
29.33%
Perf 3Y
-3.47%
Perf 5Y
-86.68%
Perf 10Y
-80.41%
Prev Close
9.75
Price
9.32
Change %
-4.36%
Consensus
Buy
Avg. Price Target
$13.67
Implied Upside
+46.6%
Analysts12incl. previous ratings
Rating Distribution3 Buy · 6 Hold · 3 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Oct 07, 2026Initiated
BCS logoBBarclays
Equal Weight$10+7.2%
Oct 21, 2025Resumed
SF logoSStifel
Hold$9-3.5%
Aug 27, 2025Initiated
BCS logoBBarclays
Overweight$1.50-83.9%
Jul 15, 2025Initiated
TD logoTTD Cowen
Buy$1.25-86.6%
Jun 02, 2025Resumed
HH.C. Wainwright
Buy$1.10-88.2%
Apr 10, 2025Initiated
MFG logoMMizuho
Outperform$2-78.6%
Jul 19, 2023Initiated
JEF logoJJefferies
Underperform$0.50-94.6%
Aug 19, 2021Initiated
HH.C. Wainwright
Buy$6-35.7%
Apr 01, 2021Downgrade
SSVB Leerink
Outperform → Mkt Perform$3-67.8%
Mar 05, 2021Downgrade
RJF logoRRaymond James
Mkt Perform → Underperform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROEDER DOUGLAS ADirectorAug 19 '26Buy8.9813,953125,300171,191Aug 20 06:25 PM
ROEDER DOUGLAS ADirectorMay 12 '26Buy5.5622,686126,134144,635May 13 04:15 PM
ROEDER DOUGLAS ADirectorMar 13 '26Buy5.7317,500100,275119,731Mar 16 10:44 AM
Goodnow Timothy TPresident and CEOMar 13 '26Buy5.7917,22599,733651,243Mar 16 10:44 AM
Steven EdelmanDirectorNov 10 '25Buy6.5510,00065,50074,708Nov 13 04:48 PM
ROEDER DOUGLAS ADirectorNov 07 '25Buy5.8315,00087,45099,727Nov 10 07:40 AM
Sullivan Frederick T.Chief Financial OfficerNov 07 '25Buy5.885,41531,840157,028Nov 10 07:40 AM
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
PresidentDr. Timothy T. Goodnow Ph.D.
CFOMr. Frederick T. Sullivan CPA
Chief Operating OfficerDr. Mukul Jain Ph.D.
Chief Medical Officer & DirectorDr. Francine Ratner Kaufman M.D.
Chief Commercial Officer & DirectorMr. Brian B. Hansen